Abstract
Presented at the I International Symposium on Dengue of the School of Medicine University of Sao Paulo on October 6, 2011. (1) Associate Vice-President, R&D Dengue Vaccine Program Head, Sanofi Pasteur, Lyon, France (2) Public Health Director Sanofi Pasteur, Vaccines Division Sanofi, Brazil. Pediatrician, Doctor in Medicine by Universidade de Sao Paulo. (3) Coordinator, National Program for Dengue Fever Control, Ministry of Health /Brazil. Q&A SESSION 06 OCTOBER 2011 – I INTERNATIONAL SYMPOSIUM ON DENGUE, FMUSP, SAO PAULO
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Revista do Instituto de Medicina Tropical de São Paulo
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
